We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$12.9B
AUM Growth
+$1.9B
Cap. Flow
+$442M
Cap. Flow %
3.42%
Top 10 Hldgs %
34.89%
Holding
1,323
New
145
Increased
499
Reduced
420
Closed
63

Top Buys

Rank Stock Value
1
COLD icon
Americold
COLD
+$166M
2
OHI icon
Omega Healthcare
OHI
+$102M
3
SUI icon
Sun Communities
SUI
+$98.2M
4
AIRC
Apartment Income REIT Corp.
AIRC
+$97.3M
5
DOC icon
Healthpeak Properties
DOC
+$93.5M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$261M
2
PLD icon
Prologis
PLD
+$67.9M
3
KRC icon
Kilroy Realty
KRC
+$67.2M
4
WELL icon
Welltower
WELL
+$62.1M
5
STOR
STORE Capital Corporation
STOR
+$56.9M

Sector Composition

Rank Sector Weight
1 Real Estate 60.68%
2 Technology 7.51%
3 Communication Services 3.68%
4 Healthcare 3.56%
5 Consumer Discretionary 3.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LRMR icon
1176
Larimar Therapeutics
LRMR
$387M
$1K ﹤0.01%
+29
New +$581
MGTX icon
1177
MeiraGTx Holdings
MGTX
$1.07B
$1K ﹤0.01%
82
-124
-60% -$1.75K
MNKD icon
1178
MannKind Corp
MNKD
$1.2B
$1K ﹤0.01%
437
-605
-58% -$1.59K
NGNE icon
1179
Neurogene
NGNE
$655M
$1K ﹤0.01%
+4
New +$977
NXTC icon
1180
NextCure
NXTC
$21.2M
$1K ﹤0.01%
+4
New +$517
PAHC icon
1181
Phibro Animal Health
PAHC
$1.49B
$1K ﹤0.01%
+38
New +$699
PBYI icon
1182
Puma Biotechnology
PBYI
$399M
$1K ﹤0.01%
87
-156
-64% -$1.58K
PRTA icon
1183
Prothena Corp
PRTA
$443M
$1K ﹤0.01%
+88
New +$1.04K
RAPT
1184
DELISTED
RAPT Therapeutics
RAPT
$1K ﹤0.01%
+6
New +$1.3K
RDHL
1185
Redhill Biopharma
RDHL
$4.26M
– –
0
– –
RIGL icon
1186
Rigel Pharmaceuticals
RIGL
$710M
$1K ﹤0.01%
37
-44
-54% -$1.27K
RLMD icon
1187
Relmada Therapeutics
RLMD
$536M
$1K ﹤0.01%
+31
New +$1.06K
RNAC icon
1188
Cartesian Therapeutics
RNAC
$225M
$1K ﹤0.01%
+7
New +$607
SIGA icon
1189
SIGA Technologies
SIGA
$237M
$1K ﹤0.01%
172
-339
-66% -$2.39K
SMMT icon
1190
Summit Therapeutics
SMMT
$10B
$1K ﹤0.01%
+155
New +$656
SPRO icon
1191
Spero Therapeutics
SPRO
$68.9M
$1K ﹤0.01%
+51
New +$795
SYRE icon
1192
Spyre Therapeutics
SYRE
$8.31B
$1K ﹤0.01%
4
-6
-60% -$1.24K
TCRT icon
1193
Alaunos Therapeutics
TCRT
$4.62M
$1K ﹤0.01%
+3
New +$1.19K
TXMD icon
1194
TherapeuticsMD
TXMD
$23.6M
$1K ﹤0.01%
12
-19
-61% -$1.3K
UBX
1195
DELISTED
Unity Biotechnology
UBX
$1K ﹤0.01%
12
-15
-56% -$723
URGN icon
1196
UroGen Pharma
URGN
$1.97B
$1K ﹤0.01%
48
-70
-59% -$1.47K
VSTM icon
1197
Verastem
VSTM
$519M
$1K ﹤0.01%
+27
New +$542
VYGR icon
1198
Voyager Therapeutics
VYGR
$187M
$1K ﹤0.01%
82
-150
-65% -$1.44K
WVE icon
1199
Wave Life Sciences
WVE
$1.12B
$1K ﹤0.01%
99
-114
-54% -$957
XBIT icon
1200
XBiotech
XBIT
$68.9M
$1K ﹤0.01%
64
-100
-61% -$1.84K
46 47
48
49 50

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q4 2020 Portfolio in Review

As of Q4 2020, Daiwa Securities Group held 1,323 positions worth $12.9B, up 17% from $11B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Daiwa Securities Group deployed $442M of net new capital in Q4 2020, opening 145 new positions and adding to 499 existing holdings. Its largest new stake was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, down from 62% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Equinix, an estimated $261M trimmed.

  • Daiwa Securities Group's largest Q4 2020 buy was Apartment Income REIT Corp.: 2,533,191 shares worth $97.3M.
  • Daiwa Securities Group added most to Americold in Q4 2020, an estimated $166M increase.
  • Daiwa Securities Group's biggest Q4 2020 reduction was Equinix, cutting an estimated $261M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 6.219% Corporate Units in Q4 2020, selling an estimated $16.6M.
  • Daiwa Securities Group's ten largest holdings make up 35% of its $12.9B portfolio in Q4 2020.
  • Daiwa Securities Group opened 145 new positions and closed 63 in Q4 2020.
  • Daiwa Securities Group's portfolio value rose 17% quarter-over-quarter to $12.9B.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.